|
Data Collection Sheet for Individual Centres to
Report to Regional Co-ordinating Centre
(Fill in one sheet only for each category of population
tested and type of susceptibility testing.)
1. Centre
name
Town/City
Country
WHO region
2. WHO
co-ordinating centre: Australia
3. Patient
population tested (please tick Ö )
Unknown [ ]
STD patients [ ]
Screening, case finding [ ]
4. Briefly
describe population tested
5. Gonococcal strain population tested (please tick Ö )
Consecutive (all isolates) [ ]
Sentinel (systematic samples) [ ]
Random (give details) [ ]
6. Briefly
describe strain population
7. Method
of testing, e.g. SEARO method disc or MIC (if done)
|
Data Recording Sheet
Laboratory
Date: From To
Method of testing: [specify for each antibiotic if not
using the SEAR method]
Please enter zone sizes (annular radius mm) under the
appropriate category of sensitivity for reference strains selected and test
strains. Start a new sheet for each batch.
|
Strain
|
b-lact
|
Penicillin
|
Ciprofloxacin
|
Nalidixic acid
|
Ceftriaxone
|
Spectino.
|
Tetracycline
|
|
Category
|
|
R*
|
S/LS**
|
R
|
LS
|
S
|
R/LS
|
S
|
LS
|
S
|
R
|
S
|
TRNG
|
not TRNG
|
|
ANNULAR
RADIUS (mm)
|
|
<3
|
>4
|
<6
|
>6
|
>6
|
0
|
>6
|
<6
|
>6
|
0
|
>6
|
<1
|
>2
|
|
Reference
strains
WHO A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WHO B
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WHO C#
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WHO D
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
WHO E
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Test strains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* Does not respond to penicillin
** Responds to penicillin treatment
# WHO C to be included with each batch of disc testing
Summary
Reporting Sheet for SEAR GASP Network Laboratories
Laboratory
Date: From
To
|
Antibiotics
Core group
|
Total number
of strains
tested
|
Number of strains per category
|
|
b-lactamase
|
Chromosomal resistance
|
|
Positive
|
Negative
|
Resistant
|
Less sensitive
|
Susceptible
|
|
Penicillin
|
|
|
|
|
|
|
|
Ciprofloxacin
(or other
quinolone;
specify)
|
|
|
|
|
|
|
|
Ceftriaxone
|
|
|
|
|
|
|
|
Spectinomycin
|
|
|
|
|
|
|
|
Tetracycline
|
|
TRNG
positive
|
TRNG
negative
|
|
|
|
|
|
|
Additional group
Thiamphenicol/
Chloramphenicol
Kanamycin
Other cephalosporins
Azithromycin
|
|
HO GASP Quality Assurance Programme
1998 QA Programme for WPR and SEARO
Batch 1: Neisseria
gonorrhoea strains 98 QA 1–6
Date tested
Laboratory
Testing method: Please tick ( )
[ ] MIC mg/L
[ ] Disc: ( ) Zone diameter or
( ) Annular radius
[ ] American
[ ] non-American: ( ) AGSP or
( ) other
Results: Please enter MIC value (mg/L) or zone size
(mm) AND Category of sensitivity for strains 1–6. Categories based on zone
sizes and MICs are contained in the Reference
Manual. If using AGSP system disc testing, annular radius (mm) replaces
zone diameter.
98 QA Strain
|
Penicillin
|
Ceftriaxone
|
Ciprofloxacin
|
Spectinomycin
|
Tetracycline
|
Nalidixic acid
|
|
Disc
potency
|
S/LS/R/PPNG
|
S or R
|
S/LS/R
|
S or R
|
TRNG or Not TRNG
|
S or R
|
|
1. MIC
|
|
|
|
|
|
|
|
Zone Size
|
|
|
|
|
|
|
|
Category
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2. MIC
|
|
|
|
|
|
|
|
Zone Size
|
|
|
|
|
|
|
|
Category
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3. MIC
|
|
|
|
|
|
|
|
Zone Size
|
|
|
|
|
|
|
|
Category
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4. MIC
|
|
|
|
|
|
|
|
Zone Size
|
|
|
|
|
|
|
|
Category
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5. MIC
|
|
|
|
|
|
|
|
Zone Size
|
|
|
|
|
|
|
|
Category
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6. MIC
|
|
|
|
|
|
|
|
Zone Size
|
|
|
|
|
|
|
|
Category
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quality Control Chart for Antimicrobial
Susceptibility Testing using SEAR GASP Network Disc Method
Control strain: N. gonorrhoeae WHO C
|
|
